doi: 10.1586/14737167.7.2.187.
Impact of dose frequency on compliance and health outcomes: a literature review (1966-2006)
Affiliations
- PMID: 20528445
- DOI: 10.1586/14737167.7.2.187
Item in Clipboard
Impact of dose frequency on compliance and health outcomes: a literature review (1966-2006)
Expert Rev Pharmacoecon Outcomes Res.
2007 Apr.
Abstract
In order for treatments to be effective, patients must be compliant with their medication regimens. Currently, patient compliance is seen as one of the most challenging issues in treating patients with chronic diseases. Studies in which dose frequency has been changed have been reviewed across several different diseases to examine the impact of a change in dose frequency on compliance and health outcomes, as well as efficacy and tolerability. In general, reducing dose frequency may improve medication compliance and effectiveness, and reduce adverse events, while possibly reducing healthcare costs. Suggestions for future research have been presented, including a need to measure compliance with injectable formulations and a standardized definition of compliance.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?Int J Evid Based Healthc. 2008 Mar;6(1):78-110. doi: 10.1111/j.1744-1609.2007.00098.x. Int J Evid Based Healthc. 2008. PMID: 21631815
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.Headache. 2008 Jun;48(6):900-13. doi: 10.1111/j.1526-4610.2007.00953.x. Epub 2007 Nov 28. Headache. 2008. PMID: 18047501 Clinical Trial.
-
[Can linking co-payment for drugs to evidence on treatment value improve health outcomes and contain healthcare costs?].Harefuah. 2010 Aug;149(8):524-8, 550. Harefuah. 2010. PMID: 21341433 Review. Hebrew.
Cited by
-
Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-naïve Children with Growth Hormone Deficiency: the Phase 3 heiGHt Trial".J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2206-e2207. doi: 10.1210/clinem/dgab878. J Clin Endocrinol Metab. 2022. PMID: 34918085 Free PMC article. No abstract available.
-
Impact of Medication Regimen Simplification on Medication Administration Times and Health Outcomes in Residential Aged Care: 12 Month Follow Up of the SIMPLER Randomized Controlled Trial.J Clin Med. 2020 Apr 8;9(4):1053. doi: 10.3390/jcm9041053. J Clin Med. 2020. PMID: 32276360 Free PMC article.
-
Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis.Patient Prefer Adherence. 2013 May 20;7:419-34. doi: 10.2147/PPA.S44646. Print 2013. Patient Prefer Adherence. 2013. PMID: 23737662 Free PMC article.
-
Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence.Arthritis Rheum. 2013 Jun;65(6):1421-9. doi: 10.1002/art.37917. Arthritis Rheum. 2013. PMID: 23728826 Free PMC article.
-
The Effect of Space Travel on Bone Metabolism: Considerations on Today's Major Challenges and Advances in Pharmacology.Int J Mol Sci. 2021 Apr 27;22(9):4585. doi: 10.3390/ijms22094585. Int J Mol Sci. 2021. PMID: 33925533 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources
